Delatestryl®: Attenuating Gout Risk in Hypogonadal American Males
Reading Time: < 1 minuteIntroduction Gout, a debilitating form of inflammatory arthritis, affects over 9 million Americans, with a disproportionate burden on males, particularly those aged 40-70. Characterized by hyperuricemia-induced monosodium urate crystal deposition in joints, gout manifests as acute, excruciating pain, often in the big toe (podagra). In the United States, where obesity, metabolic syndrome, and hypogonadism are epidemic, modifiable risk factors like... Read more »
